Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3',5'-monophosphorothioate (Sp-5,6-DCl-cBiMPS) As a Potent and Specific Activator of Cyclic-AMP-dependent Protein Kinase in Cell Extracts and Intact Cells

Overview

Journal Biochem J

Specialty Biochemistry

Date 1991 Oct 15

PMID 1659381

Citations 43

Authors

M Sandberg

E Butt

C Nolte

L Fischer

M Halbrugge

J Beltman

T Jahnsen

H G Genieser

B Jastorff

U Walter

Affiliations

Soon will be listed here.

Abstract

A newly designed cyclic AMP (cAMP) analogue, Sp-5,6-dichloro-1-beta-D- ribofuranosylbenzimidazole-3',5'-monophosphorothioate (Sp-5,6-DCl-cBiMPS), and 8-(p-chlorophenylthio)-cAMP (8-pCPT-cAMP) were compared with respect to their chemical and biological properties in order to assess their potential as activators of the cAMP-dependent protein kinases (cAMP-PK) in intact cells. Sp-5,6-DCl-cBiMPS was shown to be both a potent and specific activator of purified cAMP-PK and of cAMP-PK in platelet membranes, whereas 8-pCPT-cAMP proved to be a potent activator of cAMP-PK and cyclic-GMP-dependent protein kinase (cGMP-PK) both as purified enzymes and in platelet membranes. Sp-5,6-DCl-cBiMPS was not significantly hydrolysed by three types of cyclic nucleotide phosphodiesterases, whereas 8-pCPT-cAMP (and 8-bromo-cAMP) was hydrolysed to a significant extent by the Ca2+/calmodulin-dependent phosphodiesterase and by the cGMP-inhibited phosphodiesterase. The apparent lipophilicity, a measure of potential cell-membrane permeability, of Sp-5,6-DCl-cBiMPS was higher than that of 8-pCPT-cAMP. Extracellular application of Sp-5,6-DCl-cBiMPS to intact human platelets reproduced the pattern of protein phosphorylation induced by prostaglandin E1, a cAMP-increasing inhibitor of platelet activation. In intact platelets, Sp-5,6- DCl-cBiMPS was also more effective than 8-pCPT-cAMP in inducing quantitative phosphorylation of the 46/50 kDa vasodilator-stimulated phosphoprotein (VASP), a major substrate of cAMP-PK in platelets. As observed with prostaglandin E1, pretreatment of human platelets with Sp-5,6-DCl-cBiMPS prevented the aggregation induced by thrombin. The results suggest that Sp-5,6-DCl-cBiMPS is a very potent and specific activator of cAMP-PK in cell extracts and intact cells and, in this respect, is superior to any other cAMP analogue used for intact-cell studies. In contrast with 8-pCPT-cAMP, Sp-5,6-DCl-cBiMPS can be used to distinguish the signal-transduction pathways mediated by cAMP-PK and cGMP-PK.

Citing Articles

BK Channels in Tail Artery Vascular Smooth Muscle Cells of Normotensive (WKY) and Hypertensive (SHR) Rats Possess Similar Calcium Sensitivity But Different Responses to the Vasodilator Iloprost.

Pyanova A, Serebryakov V, Gagov H, Mladenov M, Schubert R Int J Mol Sci. 2024; 25(13).

PMID: 39000253 PMC: 11241265. DOI: 10.3390/ijms25137140.

PMCA Ca clearance in dental enamel cells depends on the magnitude of cytosolic Ca.

Bomfim G, Giacomello M, Lacruz R FASEB J. 2022; 37(1):e22679.

PMID: 36515675 PMC: 11006021. DOI: 10.1096/fj.202201291R.

Regulation of CRE-Dependent Transcriptional Activity in a Mouse Suprachiasmatic Nucleus Cell Line.

Langiu M, Bechstein P, Neumann S, Spohn G, Maronde E Int J Mol Sci. 2022; 23(20).

PMID: 36293078 PMC: 9602552. DOI: 10.3390/ijms232012226.

Mislocalization of protein kinase A drives pathology in Cushing's syndrome.

Omar M, Byrne D, Jones K, Lakey T, Collins K, Lee K Cell Rep. 2022; 40(2):111073.

PMID: 35830806 PMC: 9311266. DOI: 10.1016/j.celrep.2022.111073.

A Comparative Update on the Neuroendocrine Regulation of Growth Hormone in Vertebrates.

Velez E, Unniappan S Front Endocrinol (Lausanne). 2021; 11:614981.

PMID: 33708174 PMC: 7940767. DOI: 10.3389/fendo.2020.614981.

References

Mery P, Lohmann S, Walter U, Fischmeister R . Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci U S A. 1991; 88(4):1197-201. PMC: 50984. DOI: 10.1073/pnas.88.4.1197. View

Kaukel E, Hilz H . Permeation of dibutyryl cAMP into HeLa cells and its convesion to monobutyryl cAMP. Biochem Biophys Res Commun. 1972; 46(2):1011-8. DOI: 10.1016/s0006-291x(72)80242-0. View

Yusta B, Pascual A, Aranda A . Comparison of the effects of forskolin and dibutyryl cyclic AMP in neuroblastoma cells: evidence that some of the actions of dibutyryl cyclic AMP are mediated by butyrate. J Neurochem. 1988; 51(6):1808-18. DOI: 10.1111/j.1471-4159.1988.tb01162.x. View

Harrison S, Reifsnyder D, Gallis B, Cadd G, Beavo J . Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol Pharmacol. 1986; 29(5):506-14. View

Francis S, Noblett B, Todd B, Wells J, Corbin J . Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol Pharmacol. 1988; 34(4):506-17. View

Gillespie P, Beavo J . Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948. Mol Pharmacol. 1989; 36(5):773-81. View

Waldmann R, Nieberding M, Walter U . Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases. Eur J Biochem. 1987; 167(3):441-8. DOI: 10.1111/j.1432-1033.1987.tb13357.x. View

Waldmann R, Bauer S, Gobel C, Hofmann F, Jakobs K, Walter U . Demonstration of cGMP-dependent protein kinase and cGMP-dependent phosphorylation in cell-free extracts of platelets. Eur J Biochem. 1986; 158(1):203-10. DOI: 10.1111/j.1432-1033.1986.tb09739.x. View

EDELMAN A, Blumenthal D, KREBS E . Protein serine/threonine kinases. Annu Rev Biochem. 1987; 56:567-613. DOI: 10.1146/annurev.bi.56.070187.003031. View

10.

Walter U . Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol. 1989; 113:41-88. DOI: 10.1007/BFb0032675. View

11.

Halbrugge M, Walter U . Purification of a vasodilator-regulated phosphoprotein from human platelets. Eur J Biochem. 1989; 185(1):41-50. DOI: 10.1111/j.1432-1033.1989.tb15079.x. View

12.

Chodosh L, Fire A, Samuels M, Sharp P . 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J Biol Chem. 1989; 264(4):2250-7. View

13.

Lohmann S, Walter U . Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984; 18:63-117. View

14.

Butt E, van Bemmelen M, Fischer L, Walter U, Jastorff B . Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3',5'-monophosphorothioates. FEBS Lett. 1990; 263(1):47-50. DOI: 10.1016/0014-5793(90)80702-k. View

15.

Dostmann W, Taylor S, Genieser H, Jastorff B, Doskeland S, Ogreid D . Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. J Biol Chem. 1990; 265(18):10484-91. View

16.

Beavo J, Reifsnyder D . Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 1990; 11(4):150-5. DOI: 10.1016/0165-6147(90)90066-H. View

17.

Van Lookeren Campagne M, DIAZ F, Jastorff B, Winkler E, Genieser H, Kessin R . Characterization of the yeast low Km cAMP-phosphodiesterase with cAMP analogues. Applications in mammalian cells that express the yeast PDE2 gene. J Biol Chem. 1990; 265(10):5847-54. View

18.

Halbrugge M, Friedrich C, Eigenthaler M, Schanzenbacher P, Walter U . Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem. 1990; 265(6):3088-93. View

19.

de Wit R, Hekstra D, Jastorff B, Stec W, Baraniak J, VAN Driel R . Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases. Eur J Biochem. 1984; 142(2):255-60. DOI: 10.1111/j.1432-1033.1984.tb08279.x. View

20.

KRUH J . Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem. 1982; 42(2):65-82. DOI: 10.1007/BF00222695. View